Coherus launches Udenyca wearable injector deviceThe on-body device delivers Udenyca, a biosimilar pegfilgrastim administered the day after chemotherapy to decrease the incidence of infection as manifested by febrile neutropenia. Cardinal Health’s annual research report examines milestone year in biosimilarsThe study reveals the impact of a dramatic increase in commercially available biosimilars and progress in the areas of patient accessibility and treatment affordability. Sandoz closing Fougera facilities on Long Island, N.Y. Sandoz is closing the Fougera manufacturing and packaging facilities located in Melville and Hicksville on Long Island, N.Y. Fresenius Kabi intros generic Cytoxan Generic Cytoxan is used to treat several forms of cancer. Alvotech, Teva obtain FDA OK for Humira biosimilar Simlandi is the first citrate-free, high-concentration biosimilar to be designated interchangeable to Humira in the United States. Lupin obtains FDA OK for generic Balcoltra, launches Ganirelix Acetate Injection The FDA approved Lupin’s Minzoya and the company also is launching Ganirelix Acetate Injection. Nickel and dimed Rock-bottom pricing and product shortages are placing increasing pressures on the generic drug sector. Mark Cuban Cost Plus Drug Company partners with SHARx SHARx works with uninsured and underinsured Americans, providing their members access to options for high-cost maintenance and specialty medications. Cosette Pharmaceuticals obtains FDA OK for generic Rectiv Rectiv is used to treat moderate to severe pain caused by chronic anal fissures. AAM: Avalere study shows Medicare plans increase patient costs for generics An Avalere analysis found that fewer than half of all generic drugs are on generic formulary tiers. First Previous 42 43 44 45 46 Next Last
